PurchasingPolicy.orgPURCHASINGPOLICYBETA
← Back to Influence Map
Entity DossierOrganization

ELI LILLY & COMPANY

DC · US

Pharmaceutical/ Health Products

pharmaceuticals

Tracked direct giving

$0

Tracked donations to candidate

$0

LDA reported lobbying spend

$480,000

Connections

4

Lobbying Activity Detail

Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.

Top Lobbying Issues

HCRHealth Issues
$800K
TAXTaxation/Internal Revenue Code
$650K
MMMMedicare/Medicaid
$650K
BUDBudget/Appropriations
$650K
TRDTrade
$650K
DEFDefense
$650K
PHAPharmacy
$150K

Lobbying Firms Retained

WILLIAMS AND JENSEN, PLLC$650K
THE HARPLE GROUP, LLC$80K
DLA PIPER LLP (US)$70K

Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.

Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Relationships

TypeConnected ToDetailsSource
Lobbied forMARCH-IN Rights Proposal (NIH Framework)LDA filing: lobbied on NIH March-In Rights, period 3rd Quarter (July 1 - Sep 30), reported amount $50,000Source
Employed byWILLIAMS AND JENSEN, PLLCHired WILLIAMS AND JENSEN, PLLC to lobby on NIH March-In RightsSource
Employed byDLA PIPER LLP (US)Hired DLA PIPER LLP (US) to lobby (2nd Quarter (Apr 1 - June 30) 2024)Source
Employed byTHE HARPLE GROUP, LLCHired THE HARPLE GROUP, LLC to lobby (3rd Quarter (July 1 - Sep 30) 2024)Source